Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration (Q24246241)

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Associations of mortality with ocular disorders and an intervention of high-dose antioxidants and zinc in the Age-Related Eye Disease Study: AREDS Report No. 13

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Effects of long-term zinc supplementation on plasma thiol metabolites and redox status in patients with age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Methodology of the VECAT study: vitamin E intervention in cataract and age-related maculopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Baseline ophthalmic findings in the vitamin E, cataract and age-related maculopathy (VECAT) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Enhanced bioavailability of zeaxanthin in a milk-based formulation of wolfberry (Gou Qi Zi; Fructus barbarum L.).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

TOZAL Study: an open case control study of an oral antioxidant and omega-3 supplement for dry AMD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Beta carotene supplementation and age-related maculopathy in a randomized trial of US physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Plasma homocysteine, vitamin B12 and folate levels in age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

The effect of lutein and zeaxanthin supplementation on metabolites of these carotenoids in the serum of persons aged 60 or older.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

One-year results of a pilot study using oral 13-cis retinoic acid as a treatment for subfoveal predominantly occult choroidal neovascularization in patients with age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and colour vision.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin - the LUXEA (LUtein Xanthophyll Eye Accumulation) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Monthly consistency of macular pigment optical density and serum concentrations of lutein and zeaxanthin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Risk factors for age-related maculopathy are associated with a relative lack of macular pigment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Vitamin E in the treatment of uveitis-associated macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

The Grading and Prevalence of Macular Degeneration in Chesapeake Bay Watermen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Antioxidants and age-related eye disease. Current and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

High dose zinc increases hospital admissions due to genitourinary complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

The Wisconsin age-related maculopathy grading system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Dose-Ranging Study of Lutein Supplementation in Persons Aged 60 Years or Older

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

Associations Between Intermediate Age-Related Macular Degeneration and Lutein and Zeaxanthin in the Carotenoids in Age-Related Eye Disease Study (CAREDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

7 January 2021

Oral zinc in macular degeneration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

7 January 2021

Prevalence of age-related maculopathy. The Beaver Dam Eye Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

7 January 2021

Spinach cultigen variation for tissue carotenoid concentrations influences human serum carotenoid levels and macular pigment optical density following a 12-week dietary intervention

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

7 January 2021

Effect of niacin on retinal vascular diameter in patients with age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

7 January 2021

Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

7 January 2021

Consumption of one egg per day increases serum lutein and zeaxanthin concentrations in older adults without altering serum lipid and lipoprotein cholesterol concentrations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

7 January 2021

A 12-wk egg intervention increases serum zeaxanthin and macular pigment optical density in women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

7 January 2021

On the treatment of arteriosclerotic chorioretinopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

7 January 2021

Visaline in the treatment of age-related macular degeneration: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

7 January 2021

Effect of short-term, high-dose retinol on dark adaptation in aging and early age-related maculopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000254.PUB2

7 January 2021